Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS (Details Narrative)

INVESTMENTS (Details Narrative) ₩ / shares in Units, $ / shares in Units, ₩ in Millions						1 Months Ended			3 Months Ended
	Dec. 28, 2023 USD ($)	Dec. 28, 2023 JPY (¥)	Sep. 28, 2020 USD ($) $ / shares	Sep. 28, 2020 ₩ / shares	Oct. 31, 2018 USD ($)	Apr. 30, 2023 USD ($)	Apr. 30, 2023 KRW (₩)	Oct. 31, 2018 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2024 KRW (₩)	Dec. 31, 2023 USD ($)	Dec. 31, 2023 KRW (₩)	Apr. 30, 2023 KRW (₩)	Dec. 31, 2018 USD ($)	Oct. 31, 2018 JPY (¥)
Schedule Of Investments [Line Items]
Call option agreement date			Sep. 28, 2020
Realized net gain on investment bond						$ 106,000
Translation adjustment, net of tax									$ 18,000	$ 186,000
Net loan receivable from EJ Holdings									16,869,000			$ 16,869,000
Niihara International, Inc [Member]
Schedule Of Investments [Line Items]
Shares sale and assignment	$ 25,304	¥ 3,600,000
EJ Holdings, Inc. [Member]
Schedule Of Investments [Line Items]
Secured debt percentage					1.00%			1.00%								1.00%
Investment amount															$ 32,000
Percentage of voting interest															40.00%
Unsecured debt					$ 13,600,000			$ 13,600,000
Debt instrument, maturity date					Sep. 30, 2028
Unsecured debt, additional borrowings												2,600,000
Loan receivables									25,800,000			25,800,000
Translation adjustment, net of tax	$ 1,500,000
Net loan receivable from EJ Holdings									16,900,000
EJ Holdings, Inc. [Member] \| Japan Industrial Partners [Member]
Schedule Of Investments [Line Items]
Equity method investment, ownership percentage															60.00%
Unsecured Debt Due On December 28, 2027 [Member] \| EJ Holdings, Inc. [Member]
Schedule Of Investments [Line Items]
Debt instrument, maturity date								Dec. 28, 2027
Aggregated principal amount \| ¥																¥ 1,818,667,860
Maximum [Member]
Schedule Of Investments [Line Items]
Percentage of principal amount of convertible bond to be repurchased			50.00%
Telcon, Inc. ("Telcon") [Member]
Schedule Of Investments [Line Items]
Convertible bond maturity date			Oct. 16, 2030
Secured debt percentage			2.10%	2.10%
Convertible bond initial conversion price \| (per share)			$ 8.00	₩ 9,232
Convertible bond receivable									$ 17,500,000		₩ 23,600	$ 17,500,000	₩ 23,600
Convertible Bond Purchase Agreement [Member] \| Telcon, Inc. ("Telcon") [Member]
Schedule Of Investments [Line Items]
Purchase of principal amount of convertible bond at face value			$ 26,100,000
API Supply Agreement [Member] \| Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member]
Schedule Of Investments [Line Items]
Offset amount against principal amount of convertible bond						2,200,000								₩ 2,900
Cash proceeds to shortfall in revenue and profits						$ 236,000	₩ 307
API Supply Agreement [Member] \| Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] \| Maximum [Member]
Schedule Of Investments [Line Items]
Annual Profit			2,500,000
API Supply Agreement [Member] \| Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] \| Minimum [Member]
Schedule Of Investments [Line Items]
Annual Revenue			$ 5,000,000